Cramer’s lightning spherical: Plug Power versus Linde

Plug Power: “I like those two acquisitions, that’s why we had Plug Power on. I like the story, but I was hoping you were talking about Linde” as a result of the corporate has “a lot of things going for it. We’ll do this: Linde for the people who want to be able to have some hydrogen” and “Plug Power for those who are young — or young at heart — and are willing to take a little speculative appeal.”

Huntington Ingalls Industries: “I am not going to endorse that. If I want a defense play, I’m going to go with Raytheon …. [or] Lockheed Martin.”

Gilead Sciences: “They have a gang that can’t shoot straight … I would skip it. This whole biotech group is down big. Why not take a look at Regeneron.”

International Flavors & Fragrances: “I think that this merger they’re going to be doing with DuPont … is going to be just terrific for IFF, and the stock is a buy right here at $122.”

Karyopharm: “Cancer spec. I never say no to those … I happen to think that if you want to speculate, you want to speculate oncology because there’s so much heartbreak and there’s so much need.”

Barrick Gold: “I actually am a very big fan of Barrick Gold. I think you buy half and then … you hope it comes in.”

Precigen: “I have to do some work on that one.”

Disclosure: Cramer’s charitable belief owns shares of DuPont.


Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, feedback, recommendations for the “Mad Money” web site?

Source hyperlink

What do you think?

Written by Business Boy


Leave a Reply

Your email address will not be published. Required fields are marked *



Herbalife CEO says sales are growing as people realize that ‘well being is wealth’

Delta plans to furlough more than 1,900 pilots in October